Rhumbline Advisers Makes New Investment in Grail, Inc. (NASDAQ:GRAL)

Rhumbline Advisers bought a new position in shares of Grail, Inc. (NASDAQ:GRAL) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 25,539 shares of the company’s stock, valued at approximately $456,000. Rhumbline Advisers owned about 0.08% of Grail at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in GRAL. FNY Investment Advisers LLC purchased a new position in shares of Grail during the fourth quarter worth $26,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Grail during the fourth quarter worth about $64,000. China Universal Asset Management Co. Ltd. purchased a new stake in shares of Grail during the fourth quarter worth about $127,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of Grail during the fourth quarter worth about $244,000. Finally, Gladstone Institutional Advisory LLC purchased a new stake in shares of Grail during the fourth quarter worth about $259,000.

Analyst Ratings Changes

A number of equities analysts recently weighed in on GRAL shares. Morgan Stanley assumed coverage on shares of Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price target on the stock. Wolfe Research assumed coverage on shares of Grail in a report on Friday, November 15th. They issued a “peer perform” rating on the stock.

Grail Trading Down 1.7 %

NASDAQ:GRAL opened at $32.88 on Friday. The company’s 50-day moving average is $30.64 and its two-hundred day moving average is $20.84. Grail, Inc. has a 1-year low of $12.33 and a 1-year high of $63.99.

Grail (NASDAQ:GRAL) last released its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million during the quarter, compared to analysts’ expectations of $35.33 million. Equities research analysts predict that Grail, Inc. will post -15.15 EPS for the current year.

Grail Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.